Cargando…
Renin–angiotensin system inhibition in COVID-19 patients: Friend or foe?
Autor principal: | Karadağ, Bilgehan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414815/ https://www.ncbi.nlm.nih.gov/pubmed/32628135 http://dx.doi.org/10.14744/AnatolJCardiol.2020.40771 |
Ejemplares similares
-
Renin angiotensin system in liver diseases: Friend or foe?
por: Simões e Silva, Ana Cristina, et al.
Publicado: (2017) -
Hypertension, renin–angiotensin–aldosterone system inhibition, and COVID-19
por: Williams, Bryan, et al.
Publicado: (2020) -
Renin–Angiotensin–Aldosterone System: Friend or Foe—The Matter of Balance. Insight on History, Therapeutic Implications and COVID-19 Interactions
por: Simko, Fedor, et al.
Publicado: (2021) -
Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic
por: South, Andrew M., et al.
Publicado: (2020) -
Renin-angiotensin-aldosterone system inhibitors and the COVID-19 epidemic
por: Silva-Cardoso, José, et al.
Publicado: (2022)